Sernova Corp. (TSE:SVA – Get Free Report) shares were down 2.5% on Tuesday . The company traded as low as C$0.19 and last traded at C$0.20. Approximately 221,125 shares were traded during mid-day trading, an increase of 57% from the average daily volume of 140,500 shares. The stock had previously closed at C$0.20.
Sernova Stock Down 2.5 %
The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32. The firm has a fifty day simple moving average of C$0.22 and a 200-day simple moving average of C$0.24. The firm has a market cap of C$65.62 million, a price-to-earnings ratio of -1.88 and a beta of 1.35.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
- Five stocks we like better than Sernova
- The 3 Best Retail Stocks to Shop for in August
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What is a Special Dividend?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
